LPA3 was shown to be downregulated in HGPS patient fibroblasts through the lysosomal pathway, and it was shown to be crucial for ameliorating ROS accumulation and cell senescence in fibroblasts. The gene discussed is LPAR3; the disease is Hutchinson-Gilford progeria syndrome.